Has Lin Li received payments from drug or device companies?

Yes. Drug and device makers reported $45,265 in general payments to Lin Li across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lin Li did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lin Li come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lin Li

Internal Medicine · Mobile, ALNPI 1265910095

Payments from drug & device makers

What this record shows

This record is dominated by grants: $31,500 of the $45,265 with a category attached, or 69.6%. Abbott accounts for 75.9% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $39,818, more than ten times the $1,458 reported in 2023. Among internal medicine clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,265in general payments, 2019–2025

Across 131 payments — averaging $345.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$34K
Boston Scientific$3K
Medtronic$3K
Medical Device Business Services, Inc.$2K
Biotronik Inc.$1K
Biosense Webster, Inc.$673
plus $577 from 7 others

What the payments were for

Grants$31,50070%
Travel & lodging$7,05116%
Food & beverage$6,22614%
Education$4881%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	32	$34,357
Boston Scientific	11	$3,444
Medtronic	43	$2,952
Medical Device Business Services, Inc.	12	$1,912
Biotronik Inc.	11	$1,350
Biosense Webster, Inc.	8	$673
Angiodynamics, Inc.	2	$154
Abiomed	3	$145
E.r. Squibb & Sons, L.L.C.	2	$116
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$83
Atricure, Inc.	2	$41
Cardiva Medical, Inc.	1	$21
Amgen	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,265 in reported general payments places this provider in the 95th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	12	$211
Atorvastatin Calcium	16	$104
Lisinopril	11	$49
Amlodipine Besylate	14	$16

Paid to pharmacies, not to this prescriber.

Other internal medicine in Mobile

Thomas McKelveyMobile$365K
Mary HonkanenMobile$302K
Bobby WrightsMobile$89K
Rahel AzizMobile$67K
Jamie CaudillMobile$52K
Edward CarlosMobile$26K
Donald SandersMobile$23K
Amy StrassburgMobile$18K
Roger AlvaradoMobile$18K
Daniel PolanskyMobile$17K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →